ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED

ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Filings
  • Officers
  • Persons with significant controls
  • Insolvency
  • Data Source
  • Overview

    Company NameORLA PROTEIN TECHNOLOGIES (EBT) LIMITED
    Company StatusDissolved
    Legal FormPrivate limited company
    Company Number 08511142
    JurisdictionEngland/Wales
    Date of Creation
    Date of Cessation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryYes
    Registered Office is in DisputeNo

    What is the purpose of ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED?

    • Dormant Company (99999) / Activities of extraterritorial organisations and bodies

    Where is ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED located?

    Registered Office Address
    Suite 5 2nd Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Undeliverable Registered Office AddressNo

    What were the previous names of ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED?

    Previous Company Names
    Company NameFromUntil
    CROSSCO (1322) LIMITEDApr 30, 2013Apr 30, 2013

    What are the latest accounts for ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED?

    Last Accounts
    Last Accounts Made Up ToOct 31, 2018

    What are the latest filings for ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED?

    Filings
    DateDescriptionDocumentType

    Final Gazette dissolved following liquidation

    1 pagesGAZ2

    Return of final meeting in a members' voluntary winding up

    13 pagesLIQ13

    Liquidators' statement of receipts and payments to May 26, 2021

    13 pagesLIQ03

    Appointment of a voluntary liquidator

    3 pages600

    Removal of liquidator by court order

    5 pagesLIQ10

    Declaration of solvency

    5 pagesLIQ01

    Registered office address changed from St Ann's Wharf 112 Quayside Newcastle upon Tyne NE1 3DX United Kingdom to Suite 5 2nd Bulman House Regent Centre Gosforth Newcastle upon Tyne NE3 3LS on Jun 16, 2020

    2 pagesAD01

    Confirmation statement made on Apr 30, 2020 with no updates

    3 pagesCS01

    Appointment of a voluntary liquidator

    3 pages600

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    liquidation

    Special resolution to wind up on May 27, 2020

    LRESSP

    Change of details for Orla Protein Technologies Limited as a person with significant control on Dec 17, 2019

    2 pagesPSC05

    Register(s) moved to registered office address St Ann's Wharf 112 Quayside Newcastle upon Tyne NE1 3DX

    1 pagesAD04

    Registered office address changed from Biomedicine West Wing International Centre for Life Times Square Newcastle upon Tyne NE1 4EP United Kingdom to St Ann's Wharf 112 Quayside Newcastle upon Tyne NE1 3DX on Dec 17, 2019

    1 pagesAD01

    Total exemption full accounts made up to Oct 31, 2018

    5 pagesAA

    Confirmation statement made on Apr 30, 2019 with no updates

    3 pagesCS01

    Previous accounting period extended from Apr 30, 2018 to Oct 31, 2018

    1 pagesAA01

    Confirmation statement made on Apr 30, 2018 with no updates

    3 pagesCS01

    Register inspection address has been changed from C/O Bond Dickinson Llp St Ann's Wharf 112 Quayside Newcastle upon Tyne NE1 3DX United Kingdom to C/O Womble Bond Dickinson (Uk) Llp St Ann's Wharf 112 Quayside Newcastle upon Tyne NE1 3DX

    1 pagesAD02

    Register(s) moved to registered inspection location C/O Bond Dickinson Llp St Ann's Wharf 112 Quayside Newcastle upon Tyne NE1 3DX

    1 pagesAD03

    Termination of appointment of Frank Mitchell Roberts as a director on Oct 11, 2017

    1 pagesTM01

    Total exemption full accounts made up to Apr 30, 2017

    4 pagesAA

    Confirmation statement made on Apr 30, 2017 with updates

    5 pagesCS01

    Total exemption small company accounts made up to Apr 30, 2016

    3 pagesAA

    Annual return made up to Apr 30, 2016 with full list of shareholders

    4 pagesAR01
    Associated Filings
    CategoryDateDescriptionType
    capitalMay 05, 2016

    Statement of capital on May 05, 2016

    • Capital: GBP 1
    SH01

    Registered office address changed from City Quadrant 11 Waterloo Square Newcastle upon Tyne NE1 4DP to Biomedicine West Wing International Centre for Life Times Square Newcastle upon Tyne NE1 4EP on Feb 11, 2016

    1 pagesAD01

    Who are the officers of ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    LAKEY, Jeremy Hugh, Professor
    Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Suite 5 2nd Bulman House
    Director
    Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Suite 5 2nd Bulman House
    United KingdomBritishDirector79128660001
    NICOLSON, Sean Torquil
    112 Quayside
    NE1 3DX Newcastle Upon Tyne
    St Ann's Wharf
    United Kingdom
    Director
    112 Quayside
    NE1 3DX Newcastle Upon Tyne
    St Ann's Wharf
    United Kingdom
    United KingdomBritishSolicitor141925710001
    ROBERTS, Frank Mitchell
    International Centre For Life
    Times Square
    NE1 4EP Newcastle Upon Tyne
    Biomedicine West Wing
    United Kingdom
    Director
    International Centre For Life
    Times Square
    NE1 4EP Newcastle Upon Tyne
    Biomedicine West Wing
    United Kingdom
    ScotlandBritishDirector93462000002

    Who are the persons with significant control of ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    112 Quayside
    NE1 3DX Newcastle Upon Tyne
    St Ann's Wharf
    United Kingdom
    Apr 06, 2016
    112 Quayside
    NE1 3DX Newcastle Upon Tyne
    St Ann's Wharf
    United Kingdom
    No
    Legal FormLimited By Shares
    Country RegisteredUnited Kingdom
    Legal AuthorityUnited Kingdom
    Place RegisteredCompanies House
    Registration Number04311436
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Does ORLA PROTEIN TECHNOLOGIES (EBT) LIMITED have any insolvency cases?

    Case NumberDatesTypePractitionersOther
    1
    DateType
    May 27, 2020Commencement of winding up
    Dec 08, 2021Dissolved on
    Members voluntary liquidation
    NameRoleAddressAppointed OnCeased On
    Andrew D Haslam
    Suite 5, 2nd Floor Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Tyne And Wear
    practitioner
    Suite 5, 2nd Floor Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Tyne And Wear
    Gordon Smythe Goldie
    Suite 5, 2nd Floor Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Tyne And Wear
    practitioner
    Suite 5, 2nd Floor Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Tyne And Wear
    Antonya Allison
    Suite 5 2nd Floor Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Tyne And Wear
    practitioner
    Suite 5 2nd Floor Bulman House Regent Centre
    Gosforth
    NE3 3LS Newcastle Upon Tyne
    Tyne And Wear

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0